Financials
- Market Capitalization 1.83 B
- Employee 110
- Founded 2024
- CEO N/A
- Website www.inhibrx.com
- Headquarter Delaware, United States
- FIGI BBG01MS5Q9G3
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-10.67
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2032 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.54 USD | +3.29% | -17.60% | +14.24% | +222.22% | 1.96 B USD | ||
| 2040 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.78 USD | +1.40% | -3.02% | -1.87% | +103.52% | 1.88 B USD | ||
| 2060 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 20.53 USD | +2.14% | +3.58% | +8.00% | +27.36% | 1.83 B USD | ||
| 2067 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.42 USD | +2.70% | -0.87% | +12.87% | -27.23% | 1.83 B USD |